Publication | Closed Access

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients

Hematological MalignancyOncologyImmunologyClinical TrialsHematologyMyeloid NeoplasiaMedicineHealth Sciences